# SGLT-2 Inhibitors in the Treatment of Ascites

> **NCT05999773** · — · ACTIVE_NOT_RECRUITING · sponsor: **University of Palermo** · enrollment: 40 (estimated)

## Conditions studied

- Ascites Hepatic
- Cirrhosis, Liver
- Diabete Type 2

## Interventions

- **DRUG:** SGLT2 inhibitor

## Key facts

- **NCT ID:** NCT05999773
- **Lead sponsor:** University of Palermo
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-07-15
- **Primary completion:** 2025-07-15
- **Final completion:** 2026-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-05-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05999773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05999773, "SGLT-2 Inhibitors in the Treatment of Ascites". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05999773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*